023 — Wichita, Kansas

023 is a clinical research site located in Wichita, Kansas, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

023 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wichita

Browse all research sites in Kansas · View every site in Wichita

• Via Christi Hospital, St. Francis
• University of Kansas School of Medicine, Via Christi Regional Medical Center
• Kansas Heart Hospital
• University of Kansas School of Medicine
• Ascension Via Christi Hospital, Wichita
• Via Christi Hospital Inc. DBA Via Christi Research; Research Dept.
• Wesley Hospital
• University of Kansas Medical Center Research Institute
• University of Kansas School of Medicine-Wichita
• University of Kansas Medical Center: Wichita
• Via Christi Hospital, St. Joseph
• Kansas University Internal Medicine Midtown Clinic

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 023?

023 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 023 conducted?

023 has 1 clinical trials on record. Their work covers Epilepsy.

Is 023 accredited by Crixeo Clinical Trials?

023 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 023?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.